Have Januvia Side Effects Made You or a Loved One A Victim of Pancreatic Cancer?

The U.S. Food and Drug Administration released data in March of 2013 noting that type-2 diabetes treatment Januvia (sitagliptin) could potentially encourage pre-cancerous altering of cells of the pancreas referred to as “pancreatic duct metaplasia.”

Research conducted by the University of California Los Angeles, and the Gastroenterological Association lead experts to believe that Januvia may increase the risk for development of pancreatic cancer,  thyroid cancer, acute pancreatitis, and other serious side effects. In 2011, experts at UCLA found the likelihood of the most fatal side effect, pancreatic cancer, to be magnified greatly by the use of Januvia by nearly 2.7 times that of patients not treated with Januvia.

When compared to other type-2 diabetes medications, the Gastroenterological Association reports that use of Januvia’s generic form, sitagliptin, would increase the odds of developing cancer of the pancreas to a ratio of 6.7.

Januvia Lawsuit Information

Makers of Januvia, Merck & Co. have been taken to court for various legal accusations, including 3 wrongful death lawsuits. Victims allege that Merck and advertisers of Januvia:

• failed to warn patients regarding the severity of side effects through medical labels
• negligent misrepresentation of the medication
• neglected to test Januvia before releasing it to the market
• concealment of reports noting adverse events and studies linking Januvia to serious reactions
• did not withdraw Januvia from the market after the medication had been found to cause life-threatening side effects

Lawsuits involve class action and multi-district dangerous drug litigation covering adverse reactions related to Januvia from kidney failure or damage, pancreatitis, pancreatic cancer, and thyroid cancer. Bellwether trials are set to be held in the upcoming months.

If you have been a victim of Januvia’s side effects, you may be entitled to compensation. There are bad drug attorneys in each state; call now to get legal assistance.

Similar type-2 diabetes medications and incretin mimetics have also been linked to pancreatic cancer and adverse side effects. Learn more about serious reactions and medical information of Byetta, Victoza, Onglyza, Janumet, and Bydureon.